The Safety ,Tolerability and Efficacy Study of HepaCure in Chinese Subjects with Acute-On-Chronic Liver Failure
Phase 1
Recruiting
- Conditions
- Liver FailureHepatitisAcute on Chronic Hepatic Failure
- First Posted Date
- 2023-08-14
- Last Posted Date
- 2025-02-25
- Lead Sponsor
- Hexaell Biotech Co., Ltd.
- Target Recruit Count
- 92
- Registration Number
- NCT05989958
- Locations
- 🇨🇳
Beijing You'an Hospital affiliated to Capital Medical University, Beijing, Beijing, China
© Copyright 2025. All Rights Reserved by MedPath